192
Views
2
CrossRef citations to date
0
Altmetric
Original Research

A Non-Invasive Prediction Model for Non-Alcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Based on the Population of Northern Urumqi, China

, , , , , , ORCID Icon & show all
Pages 443-454 | Published online: 02 Feb 2021

References

  • European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol . 2016;64(6):1388–1402. doi:10.1016/j.jhep.2015.11.004 27062661
  • Doycheva I , Watt KD , Alkhouri N . Nonalcoholic fatty liver disease in adolescents and young adults: the next frontier in the epidemic. Hepatology . 2017;65(6):2100–2109. doi:10.1002/hep.29068 28103626
  • Fan N , Zhang L , Xia Z , Peng L , Wang Y , Peng Y . Sex-specific association between serum uric acid and nonalcoholic fatty liver disease in type 2 diabetic patients. J Diabetes Res . 2016;2016:3805372. doi:10.1155/2016/3805372 27382573
  • Sima A , Timar R , Vlad A , et al. Nonalcoholic fatty liver disease: a frequent condition in type 2 diabetic patients. Wien Klin Wochenschr . 2014;126(11–12):335–340. doi:10.1007/s00508-014-0530-8 24652019
  • Cai S , Li Z , Yu T , Xia M , Peng J . Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs. Infect Drug Resist . 2018;11:469–477. doi:10.2147/IDR.S163038 29662321
  • Abdeldyem SM , Goda T , Khodeir SA , Abou Saif S , Abd-Elsalam S . Nonalcoholic fatty liver disease in patients with acute ischemic stroke is associated with more severe stroke and worse outcome. J Clin Lipidol . 2017;11(4):915–919. doi:10.1016/j.jacl.2017.04.115 28579247
  • Abo-Amer EE , Sabal A , Ahmed R , Hasan NFE , Abd-Elsalam S . Relationship between helicobacter pylori infection and nonalcoholic fatty liver disease (NAFLD) in a developing country: a cross-sectional study. Diabetes Metab Syndr Obes . 2020;13:619–625. doi:10.2147/DMSO.S237866 32184641
  • Schmidt MI , Duncan BB , Bang H , et al. Identifying individuals at high risk for diabetes: the atherosclerosis risk in communities study. Diabetes Care . 2005;28(8):2013–2018. doi:10.2337/diacare.28.8.2013 16043747
  • Zhang Y , Shi R , Yu L , Ji L , Li M , Hu F . Establishment of a risk prediction model for non-alcoholic fatty liver disease in type 2 diabetes. Diabetes Ther . 2020;11(9):2057–2073. doi:10.1007/s13300-020-00893-z 32725485
  • National Bureau of Statistics of China. Population census of People’s Republic of China. 2018 Available from: http://www.stats.gov.cn/tjsj/ndsj/2018/indexeh.htm. Accessed 1 12, 2021.
  • Zhou F , Zhou J , Wang W , et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatology . 2019;70(4):1119–1133. doi:10.1002/hep.30702 31070259
  • Kromrey ML , Ittermann T , Berning M , et al. Accuracy of ultrasonography in the assessment of liver fat compared with MRI. Clin Radiol . 2019;74(7):539–546. doi:10.1016/j.crad.2019.02.014 30955836
  • Hernaez R , Lazo M , Bonekamp S , et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology . 2011;54(3):1082–1090. doi:10.1002/hep.24452 21618575
  • Chalasani N , Younossi Z , Lavine JE , et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology . 2012;55(6):2005–2023. doi:10.1002/hep.25762 22488764
  • Ratziu V , Charlotte F , Heurtier A , et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology . 2005;128(7):1898–1906. doi:10.1053/j.gastro.2005.03.084 15940625
  • Hanafy AS , Seleem WM , El-Kalla F , AbdAlkhalik Basha M , Abd-Elsalam S . Efficacy of a non-invasive model in predicting the cardiovascular morbidity and histological severity in non-alcoholic fatty liver disease. Diabetes Metab Syndr . 2019;13(3):2272–2278. doi:10.1016/j.dsx.2019.05.032 31235168
  • Xue M , Su Y , Feng Z , Wang S , Yao H . A nomogram model for screening the risk of diabetes in a large-scale Chinese population: an observational study from 345,718 participants. Sci Rep . 2020;10(1):11600.32665620
  • Xue M , Liu L , Wang S , et al. A simple nomogram score for screening patients with type 2 diabetes to detect those with hypertension: a cross-sectional study based on a large community survey in China. PLoS One . 2020;15(8):e0236957. doi:10.1371/journal.pone.0236957 32764769
  • Gavin JR , Alberti KG , Davidson MB , et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care . 2000;23(Suppl 1):S4–19.12017675
  • Gao Y , Xie X , Wang S-X , et al. Effects of sedentary occupations on type 2 diabetes and hypertension in different ethnic groups in North West China. Diab Vasc Dis Res . 2017;14(4):372–375. doi:10.1177/1479164117696050 28622744
  • Fan JG , Jia JD , Li YM , et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18: 163–166). J Dig Dis . 2011;12(1):38–44. doi:10.1111/j.1751-2980.2010.00476.x 21276207
  • Yang L , Yan K , Zeng D , et al. Association of polycyclic aromatic hydrocarbons metabolites and risk of diabetes in coke oven workers. Environ Pollut . 2017;223:305–310. doi:10.1016/j.envpol.2017.01.027 28131481
  • Ioannou K . Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis. Hormones . 2017;16(4):351–361. doi:10.14310/horm.2002.1755 29518755
  • Herrera AS Use of nicotine, analogues, thereof, precursors thereof or derivatives thereof in the treatment of various pathological processes capable of improvement with a-msh administered in prophylactic or therapeutic form. 2009.
  • Oliva-Damaso N , Oliva-Damaso E , Payan J . Acute and chronic tubulointerstitial nephritis of rheumatic causes. Rheum Dis Clin North Am . 2018;44(4):619–633. doi:10.1016/j.rdc.2018.06.009 30274627
  • National Clinical Guideline C. National Institute for Health and Clinical Excellence: Guidance. Chronic heart failure: national clinical guideline for diagnosis and management in primary and secondary care. London: Royal College of Physicians (UK) Copyright © 2010, National Clinical Guideline Centre; 2010.
  • Ocampo-Vázquez CM , Hernández-Benítez R , Iglesias-Leboreiro J , Bernardez-Zapata I , Luna MM , Cervantes-Izaguirre AP . Pediatric precordial pain, Hospital Español de México’s experience. Arch Cardiol Mex . 2019;89(1):31–37. doi:10.24875/acm.M19000004 30932083
  • Reinhardt MM , Cohen CI . Late-life psychosis: diagnosis and treatment. Curr Psychiatry Rep . 2015;17(2):1. doi:10.1007/s11920-014-0542-0 25617038
  • Brody H . Fatty liver disease. Nature . 2017;551(7681):S85.32080576
  • Booth FW , Roberts CK , Laye MJ . Lack of exercise is a major cause of chronic diseases. Compr Physiol . 2012;2(2):1143–1211. doi:10.1002/cphy.c110025 23798298
  • Suárez M , Boqué N , Del Bas JM , Mayneris-Perxachs J , Arola L , Caimari A . Mediterranean diet and multi-ingredient-based interventions for the management of non-alcoholic fatty liver disease. Nutrients . 2017;9(10):1052. doi:10.3390/nu9101052
  • Zein CO , Unalp A , Colvin R , Liu Y-C , McCullough AJ . Nonalcoholic steatohepatitis clinical research N. smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol . 2011;54(4):753–759. doi:10.1016/j.jhep.2010.07.040 21126792
  • Lonardo A , Bellentani S , Argo CK , et al. Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups. Dig Liver Dis . 2015;47(12):997–1006. doi:10.1016/j.dld.2015.08.004 26454786
  • Cai W , Fangping HE , Xuan WU , Yao H . The association of serum uric acid level with prevalence of non-alcoholic fatty liver in Uyghur and Han ethnicities. Chin J Endocrinol Metabolism . 2012;11:890–894.
  • Hamed AE , Elwan N , Naguib M , et al. Diabetes association with liver diseases: an overview for clinicians. Endocr Metab Immune Disord Drug Targets . 2019;19(3):274–280. doi:10.2174/1871530318666181116111945 30444204
  • Abdelmoemen G , Khodeir SA , Zaki AN , Kassab M , Abou-Saif S , Abd-Elsalam S . Overexpression of hepassocin in diabetic patients with nonalcoholic fatty liver disease may facilitate increased hepatic lipid accumulation. Endocr Metab Immune Disord Drug Targets . 2019;19(2):185–188. doi:10.2174/1871530318666180716100543 30009716
  • Rinella ME . Nonalcoholic fatty liver disease: a systematic review. JAMA . 2015;313(22):2263–2273. doi:10.1001/jama.2015.5370 26057287
  • Oni ET , Agatston AS , Blaha MJ , et al. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Atherosclerosis . 2013;230(2):258–267. doi:10.1016/j.atherosclerosis.2013.07.052 24075754
  • de Groot PF , Frissen MN , de Clercq NC , Nieuwdorp M . Fecal microbiota transplantation in metabolic syndrome: history, present and future. Gut Microbes . 2017;8(3):253–267. doi:10.1080/19490976.2017.1293224 28609252